Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John P Thomson

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Genome Biology|March 30, 2017
Diverse interventions that extend mouse lifespan suppress shared age-associated epigenetic changes at critical gene regulatory regionsJohn J Cole, Neil A Robertson, Mohammed Iqbal Rather, et al.
Elife|December 30, 2014
Epigenetic modification of the PD-1 (Pdcd1) promoter in effector CD4(+) T cells tolerized by peptide immunotherapyRhoanne C McPherson, Joanne E Konkel, Catriona T Prendergast, et al.
Cancer Research|May 20, 2016
Loss of Tet1-Associated 5-Hydroxymethylcytosine Is Concomitant with Aberrant Promoter Hypermethylation in Liver CancerJohn P Thomson, Raffaele Ottaviano, Elif B Unterberger, et al.
The Oncologist|January 31, 2023
The Scottish COVID Cancer Immunity Prevalence Study: A Longitudinal Study of SARS-CoV-2 Immune Response in Patients Receiving Anti-Cancer TreatmentKarin Purshouse, John P Thomson, Mahéva Vallet, et al.
Scientific Reports|May 11, 2023
Distinct histopathological features are associated with molecular subtypes and outcome in low grade serous ovarian carcinomaRobert L Hollis, John P Thomson, Juliette van Baal, et al.
Cancer Biology & Therapy|November 30, 2025
High-throughput screening identifies the activity of histone deacetylase inhibitors in patient-derived models of soft tissue sarcomaMolly R Danks, Piotr J Manasterski, Henry Beetham, et al.
Gynecologic Oncology|May 19, 2023
Whole exome sequencing of low grade serous ovarian carcinoma identifies genomic events associated with clinical outcomeJohn P Thomson, Robert L Hollis, Juliette van Baal, et al.
Iscience|January 7, 2021
A human pluripotent stem cell model for the analysis of metabolic dysfunction in hepatic steatosisMatthew C Sinton, Jose Meseguer-Ripolles, Baltasar Lucendo-Villarin, et al.
Molecular Oncology|May 26, 2025
Genomics-led approach to drug testing in models of undifferentiated pleomorphic sarcomaPiotr J Manasterski, Molly R Danks, John P Thomson, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|April 3, 2014
Phenobarbital induces cell cycle transcriptional responses in mouse liver humanized for constitutive androstane and pregnane x receptorsRaphaëlle Luisier, Harri Lempiäinen, Nina Scherbichler, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Genome Biology|March 30, 2017
Diverse interventions that extend mouse lifespan suppress shared age-associated epigenetic changes at critical gene regulatory regionsJohn J Cole, Neil A Robertson, Mohammed Iqbal Rather, et al.
Elife|December 30, 2014
Epigenetic modification of the PD-1 (Pdcd1) promoter in effector CD4(+) T cells tolerized by peptide immunotherapyRhoanne C McPherson, Joanne E Konkel, Catriona T Prendergast, et al.
Cancer Research|May 20, 2016
Loss of Tet1-Associated 5-Hydroxymethylcytosine Is Concomitant with Aberrant Promoter Hypermethylation in Liver CancerJohn P Thomson, Raffaele Ottaviano, Elif B Unterberger, et al.
The Oncologist|January 31, 2023
The Scottish COVID Cancer Immunity Prevalence Study: A Longitudinal Study of SARS-CoV-2 Immune Response in Patients Receiving Anti-Cancer TreatmentKarin Purshouse, John P Thomson, Mahéva Vallet, et al.
Scientific Reports|May 11, 2023
Distinct histopathological features are associated with molecular subtypes and outcome in low grade serous ovarian carcinomaRobert L Hollis, John P Thomson, Juliette van Baal, et al.
Cancer Biology & Therapy|November 30, 2025
High-throughput screening identifies the activity of histone deacetylase inhibitors in patient-derived models of soft tissue sarcomaMolly R Danks, Piotr J Manasterski, Henry Beetham, et al.
Gynecologic Oncology|May 19, 2023
Whole exome sequencing of low grade serous ovarian carcinoma identifies genomic events associated with clinical outcomeJohn P Thomson, Robert L Hollis, Juliette van Baal, et al.
Iscience|January 7, 2021
A human pluripotent stem cell model for the analysis of metabolic dysfunction in hepatic steatosisMatthew C Sinton, Jose Meseguer-Ripolles, Baltasar Lucendo-Villarin, et al.
Molecular Oncology|May 26, 2025
Genomics-led approach to drug testing in models of undifferentiated pleomorphic sarcomaPiotr J Manasterski, Molly R Danks, John P Thomson, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|April 3, 2014
Phenobarbital induces cell cycle transcriptional responses in mouse liver humanized for constitutive androstane and pregnane x receptorsRaphaëlle Luisier, Harri Lempiäinen, Nina Scherbichler, et al.
Pageof 5